Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.3%

1 terminated/withdrawn out of 76 trials

Success Rate

97.0%

+10.5% vs industry average

Late-Stage Pipeline

8%

6 trials in Phase 3/4

Results Transparency

31%

10 of 32 completed trials have results

Key Signals

19 recruiting10 with results

Enrollment Performance

Analytics

N/A
42(75.0%)
Phase 3
4(7.1%)
Phase 1
4(7.1%)
Phase 2
3(5.4%)
Phase 4
2(3.6%)
Early Phase 1
1(1.8%)
56Total
N/A(42)
Phase 3(4)
Phase 1(4)
Phase 2(3)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (76)

Showing 20 of 76 trials
NCT06221254Not ApplicableRecruiting

A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease

Role: collaborator

NCT07556718Phase 2Not Yet Recruiting

Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease

Role: collaborator

NCT05221281Not ApplicableActive Not Recruiting

Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care

Role: collaborator

NCT07352995Not ApplicableEnrolling By Invitation

Thermal Measurements of the Gut With a Colonoscope Compatible Thermal Probe

Role: collaborator

NCT05627128Not ApplicableActive Not Recruiting

A Culturally Tailored Dietary Intervention to Treat Crohn's Disease

Role: collaborator

NCT04283864Active Not Recruiting

Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease

Role: collaborator

NCT04835506Phase 4Active Not Recruiting

Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial

Role: collaborator

NCT04477928Recruiting

General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery

Role: collaborator

NCT07226583Not ApplicableNot Yet Recruiting

Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise

Role: collaborator

NCT03624062Phase 1Completed

MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes

Role: collaborator

NCT07273188Early Phase 1Recruiting

68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease

Role: collaborator

NCT04614168Not ApplicableCompleted

Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes

Role: collaborator

NCT07363044Not ApplicableRecruiting

A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease

Role: collaborator

NCT06348160Not ApplicableActive Not Recruiting

iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes

Role: collaborator

NCT05211869Not ApplicableCompleted

T1DTechCHW: Enhancing the Community Health Worker Model to Promote Diabetes Technology Use in Young Adults From Underrepresented Minority Groups

Role: collaborator

NCT06957028Not ApplicableRecruiting

CGM for the Early Detection and Management of Hyperglycemia in Pregnancy

Role: collaborator

NCT07219537Not ApplicableRecruiting

A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule

Role: collaborator

NCT06512597Not ApplicableRecruiting

Behavioral Therapy for Crohn's Disease

Role: collaborator

NCT04661358Phase 3Recruiting

Fenofibrate for Prevention of DR Worsening

Role: collaborator

NCT06670638Recruiting

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

Role: collaborator